stella
beta
A Phase III Study of KN026 in Combination With HB1801 ± Carboplatin as Neoadjuvant Treatment for Early or Locally Advanced HER2-Positive Breast Cancer — Stella
Recruiting
Back to Early or Locally Advanced HER2-positive Breast Cancer trials
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations
(1 site)
China
Clinical Trials Information Group, Shanghai
View full record on ClinicalTrials.gov